-  - Изменение - Объем сделки Бид- Предложение- Рыночная капитализация Дивидендная доходность Коэффициент Цена/Доход
-USD - -
Оборот: -
-Величина цены спроса: - -Величина цены предложения: - 4.08 млрдUSD - -

Описание деятельности

Dottikon ES Holding AG manufactures high-quality performance chemicals, intermediates and exclusive active pharmaceutical ingredients (APIs) for the world's leading chemical and pharmaceutical industry. The company with its production site in Dottikon (Aargau, Switzerland) is specialized in hazardous reactions and is positioning itself as strategic development and manufacturing partner. Its safety culture created over the last 100 years guides innovative uses of hazardous reactions, low-temperature and high-pressure chemistry, as well as continuous processing. This shortens conventional chemical synthesis routes, increases yields, selectivities and purities, and reduces waste. The versatile technology and equipment portfolio is used to design, develop and optimize chemical processes, and scale up from kilograms to multi-tons. The technology portfolio is built around active pharmaceutical ingredients (APIs) and performance chemicals and comprises hazardous reactions, low-temperature and high-pressure reactions as well as continuous processing.
 

Правление & Наблюдательный совет

Исполнительный директор
Dr. Markus Blocher
Правление
Marlene Born, Karin Krause, Dr. Stephan Kirschbaum, Dr. Urs Brändli, Dr. Thomas Rosatzin, Dr. Robert Dahinden, Dr. Rolf Schaller
Наблюдательный совет
Dr. Markus Blocher, Dr. Pierre-Alain Ruffieux, Dr. Bernhard Urwyler
 

Данные компании

Имя: Dottikon ES Holding AG
Адрес: Hembrunnstrasse 17,CH-5605 Dottikon
Телефон: +41-56-616-8111
Факс: -
E-mail: info@dottikon.com
Интернет: www.dottikon.com
Индустрия: Commodities
Сектор: Chemicals
Подсектор: Chemicals, diversified
Конец финансового года: 31.03
Акции в свободном обращении: 16.20%
Дата IPO: -

Связи с инвесторами

Имя: Marlene Born
IR телефон: +41-56-616-8201
IR-факс: -
IR e-mail: investor-relations@d...kon.com investor-relations@dottikon.com

Календарь компании

CW 48 | 29.11.2024 Interim Report 2nd Quarter/6 Months
CW 22 | 28.05.2025 Annual Report
CW 27 | 04.07.2025 General Shareholder Meeting
 

Основные акционеры

Markus Blocher
 
64.74%
Другие
 
19.96%
Peter Grogg
 
7.00%
Miriam Baumann
 
5.10%
UBS Fund Management AG
 
3.20%